Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Pandemic and Nonpandemic Influenza Periods

Podobne zapisy

• Erratum for Hernández et al., “Invasive Pneumococcal Disease and Influenza Activity in a Pediatric Population: Impact of PCV13 Vaccination in Epidemic and Nonepidemic Influenza Periods”
  od: Hernández, Sergi, i wsp.
  Wydane: (2020)
• Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study
  od: Domínguez, Ángela, i wsp.
  Wydane: (2017)
• Pneumococcal serotypes in children, clinical presentation and antimicrobial susceptibility in the PCV13 era
  od: Izquierdo, C., i wsp.
  Wydane: (2020)
• Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain
  od: Hernández, Sergi, i wsp.
  Wydane: (2020)
• Serotype and clonal distribution dynamics of invasive pneumococcal strains after PCV13 introduction (2011-2016): Surveillance data from 23 sites in Catalonia, Spain
  od: Ludwig, Guillermo, i wsp.
  Wydane: (2020)